Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-06-04 @ 6:50 PM
Study NCT ID:
NCT01332604
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2011-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors
Sponsor:
Genentech, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Cancers | View |
Keywords: